期刊文献+

vMIP-Ⅱ-TfN融合蛋白在毕赤酵母中的表达和纯化

Expression and Purification of vMIP-Ⅱ-TfN in Pichia pastoris
原文传递
导出
摘要 目的:构建pPIC-vMIP-II-TfN酵母表达载体,表达纯化vMIP-II-TfN融合蛋白。方法:利用PCR方法扩增编码人转铁蛋白N端半分子的基因片段,通过酶切、连接、转化等分子克隆方法构建pPIC-vMIP-II-TfN酵母表达载体;电击法转化X33酵母菌;用甲醇诱导重组酵母菌表达融合蛋白,利用硫酸铵沉淀、透析、Ni-NTA层析等技术进行蛋白纯化,SDS-PAGE和Western blot检测蛋白表达和纯化情况,利用趋化实验进行纯化蛋白活性检测。结果:经过两次PCR扩增了一个长约1.1kb的包含Xba I酶切位点的IgG3-TfN基因片段,插入pPIC-vMIP-II的Xba I酶切位点,经菌液PCR鉴定获得重组子,测序结果表明构建载体pPIC-vMIP-II-TfN的表达框正确无误,转化X33酵母菌,用甲醇诱导表达出48kDa的vMIP-II-TfN融合蛋白,经硫酸铵沉淀、透析、Ni-NTA纯化后得到纯度约为95%的vMIP-II-TfN融合蛋白。Western印迹结果表明融合蛋白能与转铁蛋白抗体特异性结合。活性检测表明经过诱导表达的vMIP-II-TfN融合蛋白具有趋化抑制活性。结论:成功构建pPIC-vMIP-II-TfN酵母表达载体,重组酵母工程菌经甲醇诱导成功表达出vMIP-II-TfN融合蛋白,纯化后的vMIP-II-TfN融合蛋白具有趋化抑制活性。 Objective: To construct the pPIC-vMIP-II-TfN yeast expression vector and to express vMIP-II-TfN fusion protein.Method: PCR was employed to amplify the N-terminal half-molecular of human transferrin gene.Molecular cloning methods including digestion,ligation and transformation were used to construct the pPIC-vMIP-II-TfN yeast expression vector.The linearized pPIC-vMIP-II-TfN was transformed into Pichia pastoris X33 strain by electroporation.The transformant was induced by methanol to express target protein and ammonium sulfate precipitation,dialysis,and Ni-NTA affinity chromatography were used to purify the target protein.SDS-PAGE and Western blot was used to detect the expression and purification of vMIP-II-TfN.The activity of vMIP-II-TfN was detected by chemotaxis inhibition activity assay.Results: A 1.1kb IgG3-TfN DNA fragment containing the Xba I site was amplified and it was inserted into Xba I sites of pPIC-vMIP-II.After PCR identification and sequencing,the recombinant plasmid pPIC-vMIP-II-TfN was obtained successfully and the open reading frame was correctly.The linearized pPIC-vMIP-II-TfN by Sac I was transformed into Pichia pastoris X33 strain.After inducing with methanol for 72 h,the transformant was confirmed to express a recombinant protein with molecular mass of 48 kDa by SDS-PAGE and Western blot.After characterization,the vMIP-II-TfN fusion protein was successfully purified from the supernatant of the broth using ammonium sulfate precipitation,dialysis and affinity chromatography.Furthermore,in vitro bioacitivity assay indicated that vMIP-II-TfN has chemotaxis inhibition activity.Conclusion: The pPIC-vMIP-II-TfN yeast expression vector was constructed successfully.The transformant can express the vMIP-II-TfN fusion protein which had chemotaxis inhibition activity.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2011年第10期23-28,共6页 China Biotechnology
基金 国家自然科学基金资助项目(30700704)
关键词 VMIP-II 转铁蛋白 蛋白表达 纯化 vMIP-II Transferrin Protein expression Purification
  • 相关文献

参考文献15

  • 1Shao W, Fernandez E, Sachpatzidis A, et al. CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structure. Eur J Biochem, 2001, 268(10):2948-2959.
  • 2Kledal T N, Rosenkilde M M, Coulin F, et al. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science, 1997, 277:1656-1659.
  • 3Holst P J, Luttichau H R, Schwartz T W, et al. Virally encoded chemokines and chemokine receptors in the role of viral infections. Contrib Microbiol, 2003, 10:232-252.
  • 4Morris K V, Higgins J, Shen X, et al. The effects of HHV-8 vMIP-II on SIVmac251 infection and replication competent and incompetent SIVmac239Delta3 vectors. Virus Research, 2003, 94:103-112.
  • 5莫雪梅,叶石敦,张光,孙晗笑.广谱趋化因子受体结合物-vMIP-II的体内抗SIV功能研究[J].中国病毒学,2005,20(5):459-463. 被引量:4
  • 6Widera A, Norouziyan F, Shen W C. Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery. Adv Drug Deliv Rev, 2003, 55(11):1439-1466.
  • 7Bai Y, Ann D K, Shen W C. Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent. Proc Natl Acad Sci USA, 2005, 102(20):7292-7296.
  • 8Sallach R E, Conticello V P, Chaikof E L. Expression of a recombinant elastin-like protein in Pichia pastoris. Biotechnol Prog, 2009, 25(6):1810-1818.
  • 9Cregg J M, Vedvick T S, Raschke W C. Recent advances in the expression of foreign genes in Pichia pastoris. Biotechnology, 1993, 11(8):905-910.
  • 10Daly R, Hearn M T. Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production. J Mol Recognit, 2005, 18(2):119-138.

二级参考文献14

  • 1Douglas W L, Richard Y, Edward H Q. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumor. Nature Medicine, 1997, 3 (12):1362~1368
  • 2Ali S A, Joao H C, Hammerschmid F, et al. Transferrin trojan horse as a rational approach for the biological delivery of therapeutic peptide domain. J Biol Chem, 1999, 274 (34): 24066~24073
  • 3Steinlein L M, Graf S T, Ikeda R A. Production and purification of N-terminal half-transferrin in Pichia pastoris. Protein Expression and Purification, 1995, 6 (5): 619~624
  • 4Stuart A A, Heidi C J, Robert C, et al. High-yield production of functionally active human serum transferring using a baculovirus expression system, and its structrural characterization. Biochem J,1996, 319 (Pt 1): 191~195
  • 5Cregg J M, Cereghino J L, Shi J Y, et al. Recombinant Protein Expression in Pichia pastoris. Molcular Biotechnology, 2000, 16(1):23~52
  • 6Cereghino J L, Cregg J M. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiology Rev,2000, 24 (1):45~66
  • 7Li H, Sun H, Qian Z M. The role of the transferring-transferrin-receptor system in drug delivery and targeting. Trends Pharmacol Sci, 2002, 23 (5): 206~209
  • 8Langer R. Drug delivery and targeting. Nature, 1998, 392(6679suppl): 5-10
  • 9Qian Z M, Li H Y, Sun H Z, et al. Targeted drug delivery via the transferring receptor-mediated endocytosis pathway.Pharmacological Reviews, 2002, 54 (4): 561~587
  • 10Dalmastri C, Valenti P, Visca P, et al. Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface.Microbiologica, 1998, 11 (3): 225~230

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部